Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > ** new BUY rating, price target 11$ /link **

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon Apr 15, 2021 9:41am

15 Views

Post# 32999577

RE: new BUY rating, price target 11$ /link

LIAR!!!! Stups, three of those are from 2020 and not as you claim within the last 3 months.

Almost no one covering this. Well Piper Sandler is but they also made money off the private placement.

Your a LIAR Stups. Desperate and no credibility.

realstocky wrote:
Based on 4 analysts offering recommendations for lmnl in the last 3 months.

Analyst Firms Making Recommendations

BLOOM BURTON&CO

ECHELON WEALTH

H C WAINWRIGHT

PIPER SANDLER

Analyst

$11

https://www.nasdaq.com/market-activity/stocks/lmnl/analyst-research